Succinic Acid

Succinic Acid

SCHEMBL27577799

CC(=O)OC(=O)c1ccccc1C(=O)OC(C)=O.CC(=O)OC(=O)c1ccccc1C(=O)OC(C)=O.O=C(O)CCC(=O)O

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRB1CDK4CDK6CHRM2CHRM3DPP4DRD2DRD3DRD4EGFRHRH1HTR1BHTR1DHTR1FHTR2AHTR2CHTR4SLC6A2SLC6A4

The experimentally established mechanism targets of Succinic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 7/20 0.47
▸ ALDH1A1 P00352 9/20 0.44
▸ NR4A2 P43354 1/20 0.44
▸ HSD17B10 Q99714 3/20 0.43
▸ KDM4E B2RXH2 2/20 0.43
▸ TDP1 Q9NUW8 2/20 0.43
▸ HPGD P15428 2/20 0.43
▸ ESR1 P03372 1/20 0.43
▸ ITGB3 P05106 1/20 0.43
▸ ITGA2B P08514 1/20 0.43
▸ HMGB1 P09429 1/20 0.43
▸ GGT1 P19440 1/20 0.43
▸ PTGS1 P23219 1/20 0.43
▸ PTGS2 P35354 1/20 0.43
▸ BLM P54132 1/20 0.43
▸ NAPRT Q6XQN6 1/20 0.43
▸ ITGB1 P05556 1/20 0.43
▸ ITGA5 P08648 1/20 0.43
▸ LMNA P02545 3/20 0.42
▸ CYP1A2 P05177 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Succinic Acid SCHEMBL28992465 1.00 TSHR (0.47) TSHRALDH1A1NR4A2HSD17B10KDM4E
Succinic Acid SCHEMBL28992466 0.95 ALDH1A1 (0.49) TSHRALDH1A1NR4A2HSD17B10KDM4E
Butyric Acid SCHEMBL29276448 0.91 ALDH1A1 (0.49) TSHRALDH1A1HSD17B10KDM4ETDP1
SCHEMBL27928279 0.88 ALDH1A1 (0.54) TSHRALDH1A1HSD17B10KDM4ETDP1
Acetic Acid SCHEMBL28536661 0.88 TSHR (0.48) TSHRALDH1A1HSD17B10KDM4ETDP1
SCHEMBL2778 0.88 TSHR (0.52) TSHRALDH1A1HSD17B10KDM4ETDP1
SCHEMBL30084385 0.88 TSHR (0.52) TSHRALDH1A1HSD17B10KDM4ETDP1
Acetone SCHEMBL29281281 0.86 TSHR (0.50) TSHRALDH1A1HSD17B10KDM4ETDP1
SCHEMBL1896602 0.86 TSHR (0.50) TSHRALDH1A1HSD17B10KDM4ETDP1
SCHEMBL6383298 0.86 TSHR (0.50) TSHRALDH1A1HSD17B10KDM4ETDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104918608-A Pharmaceutical compositions of CETP inhibitors REDDYS LAB LTD DR 2015-09-16 — — CN claimed
CN-1523979-A Pharmaceutical compositions of adsorbates of amorphous drug �Ʒ� 2004-08-25 — — CN claimed
CN-1418089-A Pharmaceutical composition of glycogen phosphorylase inhibitor PFIZER PROD INC (US) 2003-05-14 — — CN claimed
CN-109078015-A The solid dosage of orexin receptor antagonists 默沙东公司 2018-12-25 — — CN disclosed
CN-104918608-A Pharmaceutical compositions of CETP inhibitors REDDYS LAB LTD DR 2015-09-16 — — CN disclosed
CN-104321059-A solid dosage formulations of orexin receptor antagonists MERCK SHARP & DOHME 2015-01-28 — — CN disclosed
CN-102026612-A Modification of particulate-stabilised fluid-fluid interfaces UNILEVER PLC 2011-04-20 — — CN disclosed
CN-101573110-A Methods of lowering glucose levels SANOFI AVENTIS DEUTSCHLAND (DE) 2009-11-04 — — CN disclosed
CN-1787808-A Method for preparing homogeneous spray-dried solid amorphous drug dispersions using pressure nozzles PFIZER PROD INC (US) 2006-06-14 — — CN disclosed
CN-1523979-A Pharmaceutical compositions of adsorbates of amorphous drug �Ʒ� 2004-08-25 — — CN disclosed
CN-1418089-A Pharmaceutical composition of glycogen phosphorylase inhibitor PFIZER PROD INC (US) 2003-05-14 — — CN disclosed
Send feedback